What this guide is—and is not
This is an educational overview of the documentation and compliance signals a laboratory buyer might evaluate. It is not an endorsement of any supplier and not advice to purchase or use any compound for human use. Many research peptides are not authorized by Health Canada for human use, and this framing assumes legitimate laboratory research contexts only.
Batch-specific certificates of analysis
A core quality marker is a certificate of analysis tied to the specific lot you receive, not a generic template. It should identify the compound, state HPLC purity with an accompanying chromatogram, and confirm identity by mass spectrometry. A supplier that cannot produce lot-specific analytical documentation is a meaningful red flag.
Readable chromatograms and methods
Beyond a purity number, look for the actual HPLC trace and the analytical method used. Real chromatograms show baselines, retention times, and minor peaks. Documentation that only lists a headline percentage—or reuses the same figure across unrelated products—does not demonstrate genuine per-batch testing.
Storage, handling, and RUO framing
Credible suppliers provide storage and handling guidance (for example, keeping lyophilized material cold and protected from light) and clearly frame products as research use only (RUO). RUO labeling describes stated intended use for laboratory work; it is not a claim of legality or of safety for human use, and it does not convert a material into a medicine.
Compliance signals and red flags
Reassuring signals include transparent contact and business information, consistent lot tracking, and cautious, non-therapeutic language. Red flags include disease treatment or “cure” claims, marketing that encourages human use, dosing protocols aimed at consumers, missing batch documentation, and “too good to be true” purity with no data. Bold safety claims from a vendor deserve particular skepticism.
Sources and what they cover
These primary studies, official records and standards cover the topics linked below. The scope notes distinguish laboratory findings, human trials and regulatory records. This is a selected bibliography, not a systematic review or verification of every sentence; absence of a study here does not prove that no study exists.
- ICH Q2(R2) — Validation of Analytical Procedures (FDA guidance)
Analytical validation framework. A chromatogram alone does not validate identity, content, sterility or fitness for human use.
Relevant sections: Batch-specific certificates of analysis · Readable chromatograms and methods
- ICH Q1A(R2) — Stability Testing of New Drug Substances and Products (FDA guidance)
Stability study design and storage variables; not a universal shelf life for research peptides.
Relevant sections: Storage, handling, and RUO framing
- Health Canada (2026) — unauthorized injectable peptides bought online
Canadian safety and authorization notice for the products described. It does not establish approval status in every country.
Relevant sections: What this guide is—and is not · Storage, handling, and RUO framing · Compliance signals and red flags
FAQ
What is the most important document to look for?+
A batch-specific certificate of analysis matched to the lot you receive—identifying the compound, stating HPLC purity with a chromatogram, and confirming identity by mass spectrometry. Generic or template COAs are a red flag.
Does “research use only” mean a product is legal or safe?+
No. RUO describes the supplier's stated intended use for laboratory research. It is not a guarantee of legality or of safety for human use, and many research peptides are not authorized by Health Canada for human use.
What marketing red flags should raise concern?+
Disease treatment or cure claims, language encouraging human use, consumer dosing protocols, missing or reused batch documentation, and unrealistic purity claims with no supporting data. This guide is educational lab literacy, not an endorsement.